Author:
Lian Jun,Shao Yeqin,Potter Larry D.,Chen Ronald C.,Holmes Jordan A.,Pryser Eleanor A.,Shen Jie,Shen Dinggang,Wang Andrew Z.
Reference30 articles.
1. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer;Zelefsky;Int. J. Radiat. Oncol., Biol., Phys.,2000
2. 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy;Grimm;Int. J. Radiat. Oncol., Biol., Phys.,2001
3. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer;Morris;Urology,2009
4. Long-term outcomes in younger men following permanent prostate brachytherapy;Shapiro;J. Urol.,2009
5. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: Toxicity analysis;Zilli;Int. J. Radiat. Oncol., Biol., Phys.,2011